entertainment -WSS

entertainment

author：knowledge 2025-10-02 13:13:59 - browse：249

Monica Bertagnolli -- Health Policy coverage from STAT — Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) Jeff Chiu/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica Bertagnolli, President Biden’s nominee to run the National Institutes of Health, he said Friday.

Sanders, whose health committee oversees the confirmation of the NIH nominee, had refused to hold a hearing on Bertagnolli until the Biden administration promised more drug pricing reform.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care.

Please enter a valid email address. Privacy Policy

HHS announced Friday a deal with Regeneron on the development of the Covid-19 monoclonal antibody. That deal seems to have satisfied Sanders’ demands, though Sanders said the administration must add reasonable pricing provisions to all drugs developed with the help of government funding.

“I welcome the Biden Administration’s announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries,” Sanders said in a release.

Sen. Elizabeth Warren (D-Mass.) also had withheld support for Bertagnolli’s nomination until Bertagnolli agreed to Warren’s ethics demands. Bertagnolli agreed to not join the pharmaceutical industry or accept payment from the drug industry, until at least four years after leaving her government position.

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Mark Cuban is blaming the wrong people for high drug costs

hotspot

WSS

New oral drug delivery patch is modeled after octopus tentacles

Experts study whether long Covid risk adds up with each reinfection

Stop Congress from blocking public access to science

Will an HIV vaccine ever be a reality?

Illumina slashes 2023 revenue projections yet again

Illinois Supreme Court finds assault weapons ban constitutional

knowledge

entertainment

Sign up for D.C. Diagnosis

hotspot

How to save PrEP access — and even expand it

Biogen’s boardroom scandal saddles CEO with first crisis

State Dept. review finds Biden bears some blame for Afghanistan failures

Patients, digital health players weigh in on FTC's data privacy plan

Guidelines to prevent youth baseball injuries need more muscle

Health insurers' Q3 question: how much care are people getting?

Hepatitis C has a cure — but many Americans still lack access to it

Nobel honors Karikó and Weissman's enduring partnership

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Surge in Apellis stock fueled by confidence in safety of its eye drug

explore

CDC picks Alphabet's Verily for wasterwater surveillance contract

Lawsuit highlights wrinkle for disputes over surprise medical bills

Illumina slashes 2023 revenue projections yet again

Treatments for cramps don't cut it. Why aren't there better options?

Study points to new risk in gene therapy death of Terry Horgan

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

leisure time

hotspot

hotspot

leisure time